Literature DB >> 223076

Action of harmaline and diazepam on the cerebellar content of cyclic GMP and on the activities of two endogenous inhibitors of protein kinase.

A Szmigielski, A Guidotti.   

Abstract

The rat cerebellum contains a significant amount of cGMP-dependent protein kinase, cAMP-dependent and cyclic nucleotide-independent protein kinase, and a large concentration of protein kinase inhibitors. These inhibitors are thermostable proteins which can be separated by gel chromatography into two molecular forms: the type 1 and type 2 inhibitors of protein kinase (14). The type 1 inhibitor blocks the rat cerebellar cAMP-dependent protein kinase activity while the type 2 inhibitor blocks the cGMP-dependent protein kinase, the cAMP-dependent protein kinase, and the cyclic nucleotide-independent protein kinases. The activity of the type 2 inhibitor increased or decreased in opposite direction to changes of cerebellar cGMP content generated by injection of 10 mg/kg harmaline 2.5 mg diazepam. No changes of type 1 inhibitor were observed under these conditions. The drug-induced shift of type 2 inhibitor of protein kinase was not mediated by changes in protein synthesis because it persisted after pretreatment with cycloheximide. These results are compatible with the hypothesis that cGMP modulates phosphorylation in cerebellum by changing the relationship between cGMP-dependent protein kinase and type 2 inhibitor content.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 223076     DOI: 10.1007/bf00964143

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  19 in total

Review 1.  Cyclic nucleotides and nervous system function.

Authors:  J A Nathanson
Journal:  Physiol Rev       Date:  1977-04       Impact factor: 37.312

2.  3-Acetylpyridine: a tool to inhibit the tremor and the increase of cGMP content in cerebellar cortex elicited by harmaline.

Authors:  A Guidotti; G Biggio; E Costa
Journal:  Brain Res       Date:  1975-10-10       Impact factor: 3.252

3.  Guanosine 3':5'-cyclic monophosphate binding proteins in rat tissues.

Authors:  T M Lincoln; C L Hall; C R Park; J D Corbin
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

Review 4.  Protein kinases: aspects of their regulation and diversity.

Authors:  D A Walsh; C D Ashby
Journal:  Recent Prog Horm Res       Date:  1973

5.  An assay method for cyclic AMP and cyclic GMP based upon their abilities to activate cyclic AMP-dependent and cyclic GMP-dependent protein kinases.

Authors:  J F Kuo; P Greengard
Journal:  Adv Cyclic Nucleotide Res       Date:  1972

6.  Krebs EG: Purification and characterization of a protein inhibitor of adenosine 3',5'-monophosphate-dependent protein kinases.

Authors:  D A Walsh; C D Ashby; C Gonzalez; D Calkins; E H Fischer
Journal:  J Biol Chem       Date:  1971-04-10       Impact factor: 5.157

7.  Focussed microwave radiation: a technique to minimize post mortem changes of cyclic nucleotides, dopa and choline and to preserve brain morphology.

Authors:  A Guidotti; D L Cheney; M Trabucchi; M Doteuchi; C Wang
Journal:  Neuropharmacology       Date:  1974-12       Impact factor: 5.250

8.  Changes of kinetic constant of striatal tyrosine hydroxylase elicited by neuroleptics that impair the function of dopamine receptors.

Authors:  B Zivkovic; A Guidotti
Journal:  Brain Res       Date:  1974-10-25       Impact factor: 3.252

9.  Guanosine 3':5'-monophosphate-dependent protein kinase from bovine cerebellum. Purification and characterization.

Authors:  Y Takai; K Nishiyama; H Yamamura; Y Nishizuka
Journal:  J Biol Chem       Date:  1975-06-25       Impact factor: 5.157

10.  Possible role of gamma aminobutyric acid (GABA) in the regulation of cAMP system in rat anterior pituitary.

Authors:  A Guidotti; S R Naik; A Kurosawa
Journal:  Psychoneuroendocrinology       Date:  1977       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.